SAN FRANCISCO, CA – (September 2, 2025) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors who purchased Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) common stock in or traceable to Lineage’s July 2024 initial public offering (“IPO”) to contact us immediately regarding the pending securities class action against Lineage.
SAN FRANCISCO, CA – (August 1, 2025) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Fiserv, Inc. (“Fiserv”) (NYSE: FI) who purchased or otherwise acquired Fiserv common stock between July 24, 2024 and July 22, 2025, inclusive (the “Class Period”) to contact us immediately regarding the pending securities class
SAN FRANCISCO, CA – (December 21, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in National Instruments Corporation (“National Instruments” or “NATI” or the “Company”) (NASDAQ: NATI) who suffered losses from selling NATI common stock between May 25, 2022 and January 17, 2023 to contact us immediately regarding a
SAN FRANCISCO, CA – (December 14, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Dollar General Corporation (“Dollar General” or the “Company”) (NYSE: DG) who suffered losses from purchasing or otherwise acquiring the securities of Dollar General between May 28, 2020 and August 31, 2023 to contact us
SAN FRANCISCO, CA – (December 11, 2023) – National plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) who suffered losses from purchasing or otherwise acquiring FMC common stock between February 9, 2022 and October 30, 2023 to contact us immediately regarding a pending
SAN FRANCISCO, CA – (November 9, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in DocGo Inc. (“DocGo” or the “Company”) (Nasdaq: DCGO) who suffered losses from purchasing or otherwise acquiring the securities of DocGo between November 8, 2022 and September 17, 2023 to contact us immediately regarding a